Gene-specific mechanisms direct Glucocorticoid Receptor-driven repression of inflammatory response genes in macrophages

  1. Maria A Sacta
  2. Bowranigan Tharmalingam
  3. Maddalena Coppo
  4. David A Rollins
  5. Dinesh K Deochand
  6. Bradley Benjamin
  7. Li Yu
  8. Bin Zhang
  9. Xiaoyu Hu
  10. Rong Li
  11. Yurii Chinenov
  12. Inez Rogatsky  Is a corresponding author
  1. Hospital for Special Surgery, United States
  2. Hospital For Special Surgery, United States
  3. Tsinghua University, China
  4. The University of Texas Health Science Center at San Antonio, United States

Abstract

The Glucocorticoid Receptor (GR) potently represses macrophage-elicited inflammation, however, the underlying mechanisms remain obscure. Our genome-wide analysis in mouse macrophages reveals that pro-inflammatory paused genes, activated via global negative elongation factor (NELF) dissociation and RNA Polymerase (Pol)2 release from early elongation arrest, and non-paused genes, induced by de novo Pol2 recruitment, are equally susceptible to acute glucocorticoid repression. Moreover, in both cases the dominant mechanism involves rapid GR tethering to p65 at NF-kB binding sites. Yet, specifically at paused genes, GR activation triggers widespread promoter accumulation of NELF, with myeloid cell-specific NELF deletion conferring glucocorticoid resistance. Conversely, at non-paused genes, GR attenuates the recruitment of p300 and histone acetylation, leading to a failure to assemble BRD4 and Mediator at promoters and enhancers, ultimately blocking Pol2 initiation. Thus, GR displays no preference for a specific pro-inflammatory gene class, however, it effects repression by targeting distinct temporal events and components of transcriptional machinery.

Data availability

The following data sets were generated

Article and author information

Author details

  1. Maria A Sacta

    Research Institute, Hospital for Special Surgery, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Bowranigan Tharmalingam

    Research Institute, Hospital for Special Surgery, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Maddalena Coppo

    Research Institute, Hospital for Special Surgery, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. David A Rollins

    Research Institute, Hospital For Special Surgery, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Dinesh K Deochand

    Research Institute, Hospital for Special Surgery, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Bradley Benjamin

    Research Institute, Hospital for Special Surgery, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Li Yu

    Tsinghua-Peking Center for Life Sciences, Tsinghua University, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  8. Bin Zhang

    Institute for Immunology, Tsinghua University, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6232-6768
  9. Xiaoyu Hu

    Research InstituteInstitute for Immunology, Hospital for Special Surgery, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Rong Li

    Department of Molecular Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6471-6580
  11. Yurii Chinenov

    Research Institute, Hospital for Special Surgery, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Inez Rogatsky

    Research Institute, Hospital for Special Surgery, New York, United States
    For correspondence
    rogatskyi@hss.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3514-5077

Funding

National Institutes of Health (R01DK099087)

  • Maria A Sacta
  • Bowranigan Tharmalingam
  • Maddalena Coppo
  • David A Rollins
  • Dinesh K Deochand
  • Bradley Benjamin
  • Yurii Chinenov
  • Inez Rogatsky

National Natural Science Foundation of China (91642115)

  • Li Yu
  • Bin Zhang
  • Xiaoyu Hu

National Natural Science Foundation of China (8151101184)

  • Li Yu
  • Bin Zhang
  • Xiaoyu Hu

U.S. Department of Defense (PR130049)

  • Bowranigan Tharmalingam
  • Maddalena Coppo
  • Yurii Chinenov
  • Inez Rogatsky

Rheumatology Research Foundation

  • David A Rollins
  • Yurii Chinenov
  • Inez Rogatsky

Hospital for Special Surgery David Rosensweig Genomic Center

  • Maddalena Coppo
  • Yurii Chinenov
  • Inez Rogatsky

Ministry of Science and Technology of the People's Republic of China

  • Li Yu
  • Bin Zhang
  • Xiaoyu Hu

National Natural Science Foundation of China (81422019)

  • Li Yu
  • Bin Zhang
  • Xiaoyu Hu

Tsinghua University

  • Li Yu
  • Bin Zhang
  • Xiaoyu Hu

National Institutes of Health (R01 CA220578)

  • Rong Li

National Natural Science Foundation of China (81571580)

  • Li Yu
  • Bin Zhang
  • Xiaoyu Hu

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. Mice were maintained in the Weill Cornell Animal Facility in compliance with guidelines from the Weill Cornell Animal Care and Use Committee (Protocol approval # 2015-0050).

Copyright

© 2018, Sacta et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,548
    views
  • 556
    downloads
  • 56
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Maria A Sacta
  2. Bowranigan Tharmalingam
  3. Maddalena Coppo
  4. David A Rollins
  5. Dinesh K Deochand
  6. Bradley Benjamin
  7. Li Yu
  8. Bin Zhang
  9. Xiaoyu Hu
  10. Rong Li
  11. Yurii Chinenov
  12. Inez Rogatsky
(2018)
Gene-specific mechanisms direct Glucocorticoid Receptor-driven repression of inflammatory response genes in macrophages
eLife 7:e34864.
https://doi.org/10.7554/eLife.34864

Share this article

https://doi.org/10.7554/eLife.34864

Further reading

    1. Chromosomes and Gene Expression
    Ryo Kariyazono, Takashi Osanai
    Research Article

    The hox operon in Synechocystis sp. PCC 6803, encoding bidirectional hydrogenase responsible for H2 production, is transcriptionally upregulated under microoxic conditions. Although several regulators for hox transcription have been identified, their dynamics and higher-order DNA structure of hox region in microoxic conditions remain elusive. We focused on key regulators for the hox operon: cyAbrB2, a conserved regulator in cyanobacteria, and SigE, an alternative sigma factor. Chromatin immunoprecipitation sequencing revealed that cyAbrB2 binds to the hox promoter region under aerobic conditions, with its binding being flattened in microoxic conditions. Concurrently, SigE exhibited increased localization to the hox promoter under microoxic conditions. Genome-wide analysis revealed that cyAbrB2 binds broadly to AT-rich genome regions and represses gene expression. Moreover, we demonstrated the physical interactions of the hox promoter region with its distal genomic loci. Both the transition to microoxic conditions and the absence of cyAbrB2 influenced the chromosomal interaction. From these results, we propose that cyAbrB2 is a cyanobacterial nucleoid-associated protein (NAP), modulating chromosomal conformation, which blocks RNA polymerase from the hox promoter in aerobic conditions. We further infer that cyAbrB2, with altered localization pattern upon microoxic conditions, modifies chromosomal conformation in microoxic conditions, which allows SigE-containing RNA polymerase to access the hox promoter. The coordinated actions of this NAP and the alternative sigma factor are crucial for the proper hox expression in microoxic conditions. Our results highlight the impact of cyanobacterial chromosome conformation and NAPs on transcription, which have been insufficiently investigated.

    1. Cancer Biology
    2. Chromosomes and Gene Expression
    Raphael Vidal, Eoin Leen ... Gabriele Büchel
    Research Article

    MYC family oncoproteins regulate the expression of a large number of genes and broadly stimulate elongation by RNA polymerase II (RNAPII). While the factors that control the chromatin association of MYC proteins are well understood, much less is known about how interacting proteins mediate MYC’s effects on transcription. Here, we show that TFIIIC, an architectural protein complex that controls the three-dimensional chromatin organisation at its target sites, binds directly to the amino-terminal transcriptional regulatory domain of MYCN. Surprisingly, TFIIIC has no discernible role in MYCN-dependent gene expression and transcription elongation. Instead, MYCN and TFIIIC preferentially bind to promoters with paused RNAPII and globally limit the accumulation of non-phosphorylated RNAPII at promoters. Consistent with its ubiquitous role in transcription, MYCN broadly participates in hubs of active promoters. Depletion of TFIIIC further increases MYCN localisation to these hubs. This increase correlates with a failure of the nuclear exosome and BRCA1, both of which are involved in nascent RNA degradation, to localise to active promoters. Our data suggest that MYCN and TFIIIC exert an censoring function in early transcription that limits promoter accumulation of inactive RNAPII and facilitates promoter-proximal degradation of nascent RNA.